Skip to main content

Advertisement

Table 4 Number of bleeding cases by dose of dabigatran

From: Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration

Classification of bleeding Total (n = 701) 150 mg and 110 mg twice daily (n = 675) 75 mg twice daily (n = 26) P-value
Major bleeding 11 (1.6%) 11 (1.6%) 0 (0.0%) 1.000
Any bleeding 57 (8.1%) 54 (8.0%) 3 (11.5%) 0.461